The 35-year-old Pathan had provided a urine sample as part of the BCCI's anti-doping testing program during a domestic T20 competition and his samples were subsequently tested and found to contain Terbutaline. Which is prohibited both In and Out of Competition.
The all- rounder was charged with the "commission of an Anti-Doping Rule Violation (ADRV) under the BCCI Anti- Doping Rules (ADR) Article 2.1 and provisionally suspended pending determination of the charge".
"Mr Pathan responded to the charge by admitting the ADRV and asserting that it was caused by his ingestion of a medication containing Terbutaline that had been mistakenly given to him instead of the medication prescribed for him, which did not contain any prohibited substance," the BCCI explained.
Having considered all of the evidence and taken expert external advice, the BCCI has accepted Mr Pathan's explanation of the cause of his ADRV and it is "satisfied" with Pathan's explanation that he was using the medication to "treat an Upper Respiratory Tract Infection (URTI) and not as a performance-enhancing drug".
The BCCI said Pathan had been provisionally suspended on October 28 last year and the Board has now decided to back- date the period of his final suspension from August 15.
The Board of Control for Cricket in India (BCCI) has suspended the hard-hitting all-rounder Yusuf Pathan after he was tested positive for a banned substance Terbutaline during the Ranji Trophy tournament last year. Pathan was handed a five-month retrospective suspension for failing the dope test, a sanction which ended, after the BCCI accepted that the violation was inadvertent.
"Mr Yusuf Pathan has been suspended for a doping violation. Mr Pathan had inadvertently ingested a prohibited substance, which can be commonly found in cough syrups," the BCCI said in a statement.